Teladoc Health (NYSE:TDOC) Hits New 1-Year Low on Analyst Downgrade

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday after Jefferies Financial Group lowered their price target on the stock from $10.00 to $8.00. Jefferies Financial Group currently has a hold rating on the stock. Teladoc Health traded as low as $6.38 and last traded at $6.45, with a volume of 2474952 shares. The stock had previously closed at $6.83.

TDOC has been the subject of a number of other reports. Piper Sandler decreased their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Royal Bank of Canada boosted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Bank of America decreased their price objective on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Finally, Oppenheimer lowered their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $10.82.

Insiders Place Their Bets

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.95% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of TDOC. Point72 Asset Management L.P. increased its holdings in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. lifted its holdings in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP bought a new stake in shares of Teladoc Health during the fourth quarter valued at approximately $18,348,000. Two Sigma Advisers LP raised its holdings in shares of Teladoc Health by 213.0% during the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after buying an additional 1,537,094 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after buying an additional 1,029,829 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Price Performance

The business has a 50-day simple moving average of $8.78 and a two-hundred day simple moving average of $9.59. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of -1.25 and a beta of 1.73. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. As a group, research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.